Fig. 3.
Changes in body weight of patients with type 2 diabetes during treatment with either exenatide or insulin glargine; values for each group are least square means with 95% confidence intervals from mixed model repeated measurement analysis. *p < 0.001 exenatide vs. insulin glargine at the same time point.